Skip to main content
Premium Trial:

Request an Annual Quote

Martin Madaus, Francis Lunger, Nancy Gillet, Glenn Kerkhof, Paul Oskar, and Christopher Perkin

Premium

Millipore announced last week that its new president and CEO, Martin Madaus, will start on Jan. 1, 2005. As previously announced, he is assuming the roles of president and CEO from Francis Lunger, who will remain as chairman of the board until March 1, 2005.


In connection with its integration with Inveresk Research Group, Charles River Laboratories has promoted Nancy Gillet to the post of senior vice president and president of global preclinical services. Gillet succeeds Michael Ankcorn, who is retiring from the firm effective Dec. 31. She previously served as corporate vice president and president of US preclinical services.

In addition, Charles River announced that Glenn Kerkhof was named interim president of global clinical services, succeeding Alistair McEwan, who left the company last week. Paul Oskar was promoted to general manager and president of US preclinical services from his previous position as general manager, DDS Worcester division. Christopher Perkin, the firm’s current chief operating officer of CTBR, was named general manager and president of Canadian preclinical services.